IngenioRx’s Acquisition Of ZipDrug

Fenwick & West represented ZipDrug in the transaction.

ZipDrug, an innovative pharmacy management company focused on improving the quality of pharmacy care, executed its acquisition by IngenioRx, a wholly owned subsidiary of Anthem, Inc.

This acquisition expands upon IngenioRx’s existing capabilities that focus on simplifying care and bringing clarity to costs. ZipDrug’s solutions connect consumers to high-performing pharmacies that have a proven track record of providing impactful clinical care with higher patient adherence rates, and deliver needed medications directly to a patient’s home, ultimately boosting outcomes.

The Fenwick transaction team representing ZipDrug included corporate partners Ian Goldstein (Picture) and Ethan Skerry and associates Sean Childers, Jonathan Allan, Lisa Richards, Han Ko and Jamal Johnson; executive compensation & employee benefits partner Gerald Audant, of counsel Mona Clee and counsel Laura McIntyre; employment practices counsel Matthew Damm; technology transactions partner Jonathan Millard and associate Pinar Bailey; and tax partner Larissa Neumann and associate Michael Knobler.

Involved fees earner: Jonathan Allan – Fenwick & West LLP; Gerald Audant – Fenwick & West LLP; Pinar Bailey – Fenwick & West LLP; Sean Childers – Fenwick & West LLP; Mona Clee – Fenwick & West LLP; Matthew Damm – Fenwick & West LLP; Ian Goldstein – Fenwick & West LLP; Jamal Johnson – Fenwick & West LLP; Michael Knobler – Fenwick & West LLP; Han Ko – Fenwick & West LLP; Laura McIntyre – Fenwick & West LLP; Jonathan Millard – Fenwick & West LLP; Larissa Neumann – Fenwick & West LLP; Lisa Richards – Fenwick & West LLP; Ethan Skerry – Fenwick & West LLP;

Law Firms: Fenwick & West LLP;

Clients: ZipDrug;


Author: Ambrogio Visconti